Metabiomed

059210 · KOSDAQ · Health Care · SMALL CAP

Updated terms.

Metabiomed updated a disclosed plan to buy back its own shares worth US$2.01M, about 3.0% of its market value.

Treasury Shares([Amended] Material event report (treasury share acquisition))· FILED 2026-05-14· RCEPT 20260514000715

US$2.01MBuyback amount
3.0%vs. market value

Converted at 1 USD ≈ ₩1,493.34 (filing-date rate, 2026-05-14 close)

What happened

Metabiomed updated a disclosed plan to buy back its own shares worth US$2.01M, about 3.0% of its market value.

For context, this equals about 3.0% of the company's market value.

Buyback amountUS$2.01M
vs. market value3.0%
Filed2026-05-14, [Amended] Material event report (treasury share acquisition)
SourceDART rcept 20260514000715 → open original filing

Versions of this filing

  1. 2026-05-14Original
  2. 2026-05-14Amendment 1 (this page)

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-05-14 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.